Fexofenadine Related Published Studies
Well-designed clinical trials related to Fexofenadine
Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of
fexofenadine enantiomers in Japanese volunteers. [2015]
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine
on psychomotor function and histamine-induced wheal- and flare-responses: a
randomized double-blind, placebo-controlled study in healthy volunteers. [2012]
Intranasal phototherapy is more effective than fexofenadine hydrochloride in the treatment of seasonal allergic rhinitis: results of a pilot study. [2011.03]
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. [2011.02]
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. [2011]
Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers. [2010.07]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. [2010.05]
Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS. [2010.04]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on
allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in
the Vienna Challenge Chamber. [2010]
Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis. [2009.12]
Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics. [2009.12]
Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. [2009.06]
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil. [2009.05]
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. [2009.03]
Bioequivalence of fexofenadine tablet formulations assessed in healthy Iranian volunteers. [2009]
Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit. [2009]
Fexofenadine effects on cognitive performance in aviators at ground level and simulated altitude. [2008.08]
Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis. [2007.12]
Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old. [2007.10]
The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. [2007.02]
Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare. [2007.01]
Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine. [2006.11]
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial] [2006.11]
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial] [2006.11]
Time-dependent interaction between lopinavir/ritonavir and fexofenadine. [2006.07]
A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance. [2006.07]
Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. [2006.05]
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. [2006.05]
Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. [2006.04]
Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. [2006.02]
Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis. [2006.02]
Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. [2005.10]
Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. [2005.09]
Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. [2005.09]
Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism. [2005.08]
Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit. [2005.07]
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. [2005.07]
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. [2005.06]
Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare. [2005.05]
Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults. [2005.05]
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. [2005.03]
Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. [2005.02]
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. [2005.01]
Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination. [2005.01]
Well-designed clinical trials possibly related to Fexofenadine
Does oral sodium bicarbonate therapy improve function and quality of life in
older patients with chronic kidney disease and low-grade acidosis (the BiCARB
trial)? Study protocol for a randomized controlled trial. [2015]
Closeout of the HALT-PKD trials. [2015]
Pravastatin Therapy and Biomarker Changes in Children and Young Adults with
Autosomal Dominant Polycystic Kidney Disease. [2015]
Muco-bioadhesive containing ginger officinal e extract in the management of
recurrent aphthous stomatitis: A randomized clinical study. [2015]
Add-on Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative
and Anxiety Symptoms of Schizophrenia: An 8-week, randomized, double-blind,
placebo-controlled trial. [2015]
Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection. [2015]
Probiotics for Clostridium difficile infection in adults (PICO): Study protocol
for a double-blind, randomized controlled trial. [2015]
Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using
a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial. [2015]
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone
Agonist for Endometriosis: A Randomized Controlled Trial. [2015]
Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute
myocardial infarction: double-blind, randomized controlled trial. [2015]
Effects of Vitamin K on Matrix Metalloproteinase-3 and Rheumatoid Factor in Women
with Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Trial. [2015]
Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following
Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized
Clinical Trial. [2015]
The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk
in O blood group Helicobacter pylori-infected patients: a randomized double-blind
clinical trial. [2015]
Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a
Large Double-blind Clinical Trial of Chemotherapy for Breast Cancer. [2015]
A comparative study between the efficacy of oral cimetidine and low-dose systemic
meglumine antimoniate (MA) with a standard dose of systemic MA in the treatment
of cutaneous leishmaniasis. [2015]
Huo-Luo-Xiao-Ling (HLXL)-Dan, a Traditional Chinese Medicine, for patients with
osteoarthritis of the knee: a multi-site, randomized, double-blind,
placebo-controlled phase II clinical trial. [2015]
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. [2015]
Safety and immunogenicity of a single intramuscular dose of a tetanus- diphtheria
toxoid (Td) vaccine (BR-TD-1001) in healthy Korean adult subjects. [2015]
High-cocoa polyphenol-rich chocolate improves blood pressure in patients with
diabetes and hypertension. [2015]
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study
protocol for a randomized controlled trial. [2015]
A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome: a
randomized controlled trial. [2015]
Efficacy of Benzocaine 20% Topical Anesthetic Compared to Placebo Prior to
Administration of Local Anesthesia in the Oral Cavity: A Randomized Controlled
Trial. [2015]
Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on
Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled
One-Year Intervention Trial (the SAFIR Study). [2015]
Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk
factors in obese women: a randomized controlled clinical trial. [2015]
Preventive study in subjects at risk of fatal familial insomnia: Innovative
approach to rare diseases. [2015]
Zinc sulphate: A reasonable choice for depression management in patients with
multiple sclerosis: A randomized, double-blind, placebo-controlled clinical
trial. [2015]
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated
urinary-tract infections, including pyelonephritis: a randomised, double-blind,
phase 3 trial (ASPECT-cUTI). [2015]
Effects of traditional Chinese medicine Shu Gan Jian Pi granules on patients with
breast cancer and cancer-related fatigue: study protocol for a randomized
controlled trial. [2015]
Single dose oral ibuprofen plus codeine for acute postoperative pain in adults. [2015]
Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in
Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a
randomized controlled trial. [2015]
The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for
treating Alzheimer's disease: protocol for a randomized controlled trial. [2015]
Acupuncture to Reduce HIV-Associated Inflammation. [2015]
Testosterone replacement therapy in older male subjective memory complainers:
double-blind randomized crossover placebo-controlled clinical trial of
physiological assessment and safety. [2015]
A Prospective, Split-Face, Randomized, Double-Blind Study Comparing
OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles. [2015]
Short-term blood pressure variability in acute stroke: post hoc analysis of the
controlling hypertension and hypotension immediately post stroke and continue or
stop post-stroke antihypertensives collaborative study trials. [2015]
Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile
in type 2 diabetic patients: a randomized double-blind placebo-controlled
clinical trial. [2015]
The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1
Trial. [2015]
Efficacy and safety of sublingual immunotherapy for two seasons in patients with
Japanese cedar pollinosis. [2015]
Treatment efficacy of sacral nerve stimulation in slow transit constipation: a
two-phase, double-blind randomized controlled crossover study. [2015]
Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE)
study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week
non-inferiority trial comparing Durolane to Artz. [2015]
The acute effect of beta-guanidinopropionic acid versus creatine or placebo in
healthy men (ABC Trial): study protocol for a randomized controlled trial. [2015]
Pulsed electromagnetic field therapy promotes healing and microcirculation of
chronic diabetic foot ulcers: a pilot study. [2015]
Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with
epilepsy. [2015]
Time to prerandomization monthly seizure count in perampanel trials: A novel
epilepsy endpoint. [2015]
A phase Ib multiple ascending dose study of the safety, tolerability, and central
nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease. [2015]
Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung
cancer patients with epidermal growth factor receptor mutations: study protocol
for a randomized controlled trial. [2015]
Laser therapy for onychomycosis in patients with diabetes at risk for foot
complications: study protocol for a randomized, double-blind, controlled trial
(LASER-1). [2015]
Randomized phase II/III clinical trial of elpamotide for patients with advanced
pancreatic cancer: PEGASUS-PC Study. [2015]
Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised,
double-blind, placebo-controlled trial. [2015]
Effects of Probiotic Supplementation on Oxidative Stress Indices in Women with
Rheumatoid Arthritis: A Randomized Double-Blind Clinical Trial. [2015]
A randomized clinical trial of the effects of submucosal dexamethasone after
surgery for mandibular fractures. [2015]
Reduced efficacy of sumatriptan in migraine with aura vs without aura. [2015]
Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to
severe major depression: A double-blind placebo-controlled trial. [2015]
Intranasal oxytocin administration prior to exposure therapy for arachnophobia
impedes treatment response. [2015]
Efficacy and safety of perampanel in adolescent patients with drug-resistant
partial seizures in three double-blind, placebo-controlled, phase III randomized
clinical studies and a combined extension study. [2015]
Estimated medical cost reductions for paliperidone palmitate vs placebo in a
randomized, double-blind relapse-prevention trial of patients with
schizoaffective disorder. [2015]
Brentuximab vedotin as consolidation therapy after autologous stem-cell
transplantation in patients with Hodgkin's lymphoma at risk of relapse or
progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3
trial. [2015]
|